Conformationally Locked Peptide–DNA Nanostructures for CRISPR‐Amplified Activity‐Based Sensing
Angewandte Chemie International Edition · 17.06.2025 · 64 (25)
DOI: 10.1002/anie.202500649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.04.2025. Verfasst von Dylan M Snider und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Texas at Austin, 105 E 24th St., Austin, TX 78712, USA. Hauptthemen laut MEDLINE: Peptides, DNA, CRISPR-Cas Systems, Nanostructures. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science Foundation, David and Lucile Packard Foundation, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
We introduce a new class of chemical probes for activity‐based sensing of proteases, termed cleavable, locked initiator probes (CLIPs). CLIPs contain a protease‐cleavable peptide linked between two programmable DNA strands—an “initiator” DNA and a shorter “blocking” DNA. These DNA sequences are designed to hybridize, creating a “locked” hairpin‐like structure. Upon proteolytic cleavage, the initiator strand is released, triggering the activation of CRISPR‐Cas12a enzymes and producing an amplified fluorescence response. CLIPs generate more than 20‐fold turn‐on signals at room temperature (25 °C), significantly outperforming commercial probes by yielding ∼40‐fold lower limits of detection (LOD) at 100‐fold lower concentrations. Their versatility enables the detection of various disease‐relevant proteases—including the SARS‐CoV‐2 main protease, caspase‐3, matrix metalloproteinase‐7, and cathepsin B—simply by altering the peptide sequence. Importantly, CLIPs detect cathepsin B in four different colorectal cancer cell lines, highlighting their clinical potential. Taken together, the sensitivity (LOD: ∼88 pM), selectivity, and rapid assay time (down to 35 min), combined with the ability to operate in complex biological media with minimal sample preparation, position CLIPs as powerful chemical tools for activity‐based sensing of functional enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Texas at Austin, 105 E 24th St., Austin, TX 78712, USA.
- Department of Oncology, Dell Medical School, The University of Texas at Austin, 1601 Trinity St., Austin, TX 78712, USA.
- Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, 1601 Trinity St., Austin, TX 78712, USA.
- Texas Materials Institute, The University of Texas at Austin, 2501 Speedway, Austin, TX 78712, USA.
Förderung
- National Science Foundation
- David and Lucile Packard Foundation
- Cancer Prevention and Research Institute of Texas
- American Cancer Society
Zitieren
APA
Snider, D. M., Coffin, M. L., Armijo, B. J., Khetan, R., Duchow, M. W., Capasso, A., & Samanta, D. (2025). Conformationally Locked Peptide–DNA Nanostructures for CRISPR‐Amplified Activity‐Based Sensing. Angewandte Chemie International Edition, 64(25). https://doi.org/10.1002/anie.202500649
Vancouver
Snider DM, Coffin ML, Armijo BJ, Khetan R, Duchow MW, Capasso A, et al. Conformationally Locked Peptide–DNA Nanostructures for CRISPR‐Amplified Activity‐Based Sensing. Angewandte Chemie International Edition. 2025;64(25). doi:10.1002/anie.202500649
BibTeX
@article{Snider2025,
author = {Snider, Dylan M and Coffin, Mackenzie L and Armijo, Brian J and Khetan, Ryan and Duchow, Mark W and Capasso, Anna and Samanta, Devleena},
title = {Conformationally Locked Peptide–DNA Nanostructures for CRISPR‐Amplified Activity‐Based Sensing},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {25},
doi = {10.1002/anie.202500649}
}
EUVIMED